VREOF (Vireo Growth) Selling, General, & Admin. Expense: $128.7 Mil (TTM As of Mar. 2026)


VREOF Vireo Growth Inc VREOF
47 GF Score
Price $9.95
GF Value $9.74
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Selling, General, & Admin. Expense?

Vireo Growth VREOF +1.32% 47 Selling, General, & Admin. Expense is $128.7 Mil as of Mar. 2026. GuruFocus rates VREOF with a GF Score™ of 47/100 and a GF Value™ of $9.74 (Fairly Valued). The stock has 6 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Vireo Growth's selling, general, & admin. expense for the three months ended in Mar. 2026 was $37.8 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2026 was $128.7 Mil.


Vireo Growth  (OTCPK:VREOF) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Vireo Growth Selling, General, & Admin. Expense Related Terms


Vireo Growth Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Selling, General, & Admin. Expense Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.84 36.52 32.38 31.69 99.85

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.90 16.61 33.69 40.62 37.80

VREOF vs ZTS, UTHR: Selling, General, & Admin. Expense Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth Selling, General, & Admin. Expense vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Selling, General, & Admin. Expense falls into.


VREOF
47GF Score
Vireo Growth Inc VREOF
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $128.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of $128.7 Mil mean?
Vireo Growth (VREOF) has a Selling, General, & Admin. Expense of $128.7 Mil as of Mar. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Vireo Growth and its competitors.
Is Vireo Growth's Selling, General, & Admin. Expense too high?
Vireo Growth's current Selling, General, & Admin. Expense is $128.7 Mil. Overall, Vireo Growth has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Selling, General, & Admin. Expense compare to ZTS and UTHR?
Vireo Growth's Selling, General, & Admin. Expense of $128.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Vireo Growth and its competitors. Vireo Growth's current Selling, General, & Admin. Expense is $128.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOF) is currently considered Fairly Valued. The stock's GF Value™ is $9.74, compared to a current price of $9.95 — trading 2.2% above its estimated fair value. The current Selling, General, & Admin. Expense is $128.7 Mil. Vireo Growth's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Vireo Growth (VREOF), the current Selling, General, & Admin. Expense is $128.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOF) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $9.95 is trading 2.2% above its estimated GF Value™ of $9.74. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOF:

  • Selling, General, & Admin. Expense: $128.7 Mil
  • GF Value™: $9.74 vs. price of $9.95 (2.2% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the VREOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
47GF Score

Get the complete analysis for VREOF

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.95
Price
$9.74
GF Value